financetom
Business
financetom
/
Business
/
Market Chatter: Cerebras Said to Plan Raising IPO Price Range as Demand Surges
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Cerebras Said to Plan Raising IPO Price Range as Demand Surges
May 8, 2026 1:01 PM

03:35 PM EDT, 05/08/2026 (MT Newswires) -- Cerebras Systems (CBRS) is set to raise the price range for its initial public offering to $125 to $135 per share as soon as Monday, as demand for the AI chipmaker's shares continues to build, Bloomberg reported on Friday, citing people familiar with the matter.

The company is currently marketing 28 million shares at $115 to $125 each and seeking to raise about $3.5 billion, according to SEC filings. The IPO has drawn orders for more than 20 times the number of shares available, the report said.

The report said Cerebras has been asking institutional investors to specify both the number of shares and the maximum price they are willing to pay in order to gauge the true level of demand ahead of the offering, which is expected to price on May 13.

Cerebras declined to comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Arrowhead Pharmaceuticals Swings to Loss in Fiscal Q2
Arrowhead Pharmaceuticals Swings to Loss in Fiscal Q2
May 9, 2024
04:34 PM EDT, 05/09/2024 (MT Newswires) -- Arrowhead Pharmaceuticals ( ARWR ) reported a fiscal Q2 loss late Thursday of $1.02 per diluted share, compared with earnings of $0.45 a year earlier. Analysts polled by Capital IQ expected a loss of $0.22. The company did not report any revenue for the quarter that ended March 31, compared with $146.3 million...
Onto Innovation Q1 Non-GAAP Earnings, Revenue Rise; Q2 Outlook Set; Shares Rise After Hours
Onto Innovation Q1 Non-GAAP Earnings, Revenue Rise; Q2 Outlook Set; Shares Rise After Hours
May 9, 2024
04:35 PM EDT, 05/09/2024 (MT Newswires) -- Onto Innovation ( ONTO ) reported Q1 non-GAAP earnings Thursday of $1.18 per diluted share, up from $0.92 a year earlier. Analysts polled by Capital IQ expected $1.08. Revenue in the quarter ended March 30 rose to $228.8 million from $199.2 million a year earlier. Analysts surveyed by Capital IQ expected $222.6 million....
RB Global Q1 Adjusted EPS, Revenue Increase; Shares Rise After Hours
RB Global Q1 Adjusted EPS, Revenue Increase; Shares Rise After Hours
May 9, 2024
04:33 PM EDT, 05/09/2024 (MT Newswires) -- RB Global ( RBA ) reported Q1 adjusted earnings late Thursday of $0.90 per diluted share, up from $0.57 a year earlier. Analysts polled by Capital IQ expected $0.75. Revenue for the quarter ended March 31 was $1.06 billion, up from $512.4 million a year earlier. Analysts surveyed by Capital IQ expected $1.02...
Profound Reports a Narrower First-Quarter Loss; Provides 2024 Revenue Guidance
Profound Reports a Narrower First-Quarter Loss; Provides 2024 Revenue Guidance
May 9, 2024
04:36 PM EDT, 05/09/2024 (MT Newswires) -- Profound Medical ( PROF ) on Thursday said its first quarter loss narrowed as revenue stayed flat. The company also provided annual revenue guidance for the first time. The medical device company said it lost US$6.2 million, or US$0.26 per share, in the quarter, narrowing from a loss of US$6.7 million, or US$0.32,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved